Jeff L. Vacirca

CIK: 0001724161

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CAI

Caris Life Sciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

CAI
Caris Life Sciences, Inc.
Aug 14, 2026
Award(A)
Direct
13.2K shares-
CAI
Caris Life Sciences, Inc.
May 11, 2026
Purchase(P)
Direct
31.1K shares at avg. $16.15$501K
CAI
Caris Life Sciences, Inc.
Feb 26, 2026
Award(A)
Direct
2.5K shares at avg. $20.06$50K

		Type	Shares	Price		Ownership
Aug 14, 2026	CAI Caris Life Sciences, Inc.	Award(A)	13,192	-	$0	Direct
May 11, 2026	CAI Caris Life Sciences, Inc.	Purchase(P)	31,050	$16.15	$501,426	Direct
Feb 26, 2026	CAI Caris Life Sciences, Inc.	Award(A)	2,492	$20.06	$49,990	Direct

1-3 of 3 transactions

About Vacirca Jeff L

Vacirca Jeff L (SEC CIK 0001724161) files insider reports with the SEC as Director of Caris Life Sciences, Inc. (CAI).

Signal8 holds 4 ownership filings by Vacirca Jeff L (1 Form 3, 3 Form 4), filed between Jun 17, 2025 and Aug 14, 2026. Those filings report 3 transactions, from Feb 26, 2026 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Vacirca Jeff L's filings is in IRVING, TX.

Recent filings by Vacirca Jeff L

Aug 14, 2026: Grant or award of CAI shares (Form 4, code A).
May 11, 2026: Open-market purchase of CAI shares (Form 4, code P).
Feb 26, 2026: Grant or award of CAI shares (Form 4, code A).

Other insiders filing for Caris Life Sciences, Inc. (CAI)

How to read Form 4 transaction codes